Type 1 Diabetes

More adults living with type 1 diabetes are now developing obesity, insulin resistance, hypertension, and metabolic complications once linked mainly to type 2 diabetes. This growing overlap, often called double diabetes, is becoming a major concern for clinicians and patients alike. While insulin therapy remains essential for type 1 diabetes …

The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …

The management of type 1 diabetes during pregnancy is entering a major turning point. For years, endocrinologists and maternal-fetal medicine specialists have worked within narrow therapeutic margins to reduce maternal and neonatal complications. However, new advances in automated insulin delivery technology for pregnancy are beginning to reshape glucose management in …

A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …

New advances in diabetes technology are moving beyond glucose alone. While continuous glucose monitoring transformed diabetes management over the last decade, wearable ketone monitoring systems are now emerging as the next major innovation. Researchers, device manufacturers, and international diabetes organizations are increasingly focused on whether real-time ketone data can help …

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

Can we actually prevent type 1 diabetes before symptoms appear? Increasingly, the answer is yes. As research evolves, clinicians now have stronger tools to identify at-risk children earlier and delay disease progression. This shift is especially important because type 1 diabetes often develops silently before diagnosis. Therefore, early screening and …

Can a chronic condition like type 1 diabetes be slowed before it fully develops? Recent long-term studies suggest that preventing or delaying type 1 diabetes may be closer to reality than once believed. In fact, emerging immunotherapy data is changing how clinicians view early-stage disease and the opportunity to intervene …

What happens when a patient walks into your clinic and their diabetes simply doesn’t fit the usual mold? In many cases, clinicians rely on well-established categories like Type 1 or Type 2 diabetes. However, diagnosing atypical forms of diabetes is becoming increasingly important as more patients present with mixed or …

GLP-1 receptor agonists as adjunct therapy in type 1 diabetes are gaining attention as clinicians look for new ways to improve glycemic control. But is this approach a promising tool or a risky shortcut? As emerging evidence builds, providers must balance potential benefits with safety concerns and patient-specific factors. Table …